{"name":"John Kempen","slug":"john-kempen","ticker":"","exchange":"","domain":"","description":"John Harold Kempen is an American ophthalmologist and epidemiologist currently serving as a Professor of Ophthalmology at Harvard Medical School as well as an Adjunct Professor at both Addis Ababa University and Myunsung Medical College (MMC) in Addis Ababa, Ethiopia. Kempen holds the position of Director of Global Surgery and Health at Massachusetts Eye and Ear in Boston, Massachusetts. Additionally, he is both the President and a Board Member of Sight for Souls, a nonprofit organization registered as a 501(c)(3) in the U.S.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTFA0ZEs0SVpCcms4Z1Y0V0RERjlldERzV2I5RURIc0pUU0ZkZmFNb1RIeUM5Z2NDUmdGcHhETktEaGpBNlhwdDBwV1A4S0F3NmlOSG9IeW83RUs1NFFPcEx2WlRuUkV5eXhmZldMQQ?oc=5","date":"2017-09-24","type":"deal","source":"ARVO Journals","summary":"Risk Of Cataract In Persons With Acquired Immune Deficiency Syndrome And Cytomegalovirus Retinitis - ARVO Journals","headline":"Risk Of Cataract In Persons With Acquired Immune Deficiency Syndrome And Cytomegalovirus Retinitis","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}